These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 6254020

  • 21. Two kinds of nigrostriatal asymmetry: relationship to dopaminergic drug sensitivity and 6-hydroxydopamine lesion effects in Long-Evans rats.
    Glick SD, Hinds PA, Baird JL.
    Brain Res; 1988 May 31; 450(1-2):334-41. PubMed ID: 3135915
    [Abstract] [Full Text] [Related]

  • 22. Spontaneous regeneration of nigrostriatal dopaminergic neurons in MPTP-treated C57BL/6 mice.
    Mitsumoto Y, Watanabe A, Mori A, Koga N.
    Biochem Biophys Res Commun; 1998 Jul 30; 248(3):660-3. PubMed ID: 9703982
    [Abstract] [Full Text] [Related]

  • 23. Relationship of changes in spontaneous motor activity to spontaneous circling in rats with unilateral 6-hydroxydopamine lesions of the substantia nigra.
    Carey RJ.
    Exp Neurol; 1986 Jun 30; 92(3):591-600. PubMed ID: 3086112
    [Abstract] [Full Text] [Related]

  • 24. Effects of baclofen on striatal 5-HT mediated by the nigrostriatal dopamine system.
    Waldmeier PC, Feldtrauer JJ, Kam R, Stöcklin K.
    Eur J Pharmacol; 1979 Mar 01; 54(3):279-87. PubMed ID: 428427
    [Abstract] [Full Text] [Related]

  • 25. A potential target for the treatment of Parkinson's disease: effect of lateral habenula lesions.
    Han B, Jin HJ, Song MY, Wang T, Zhao H.
    Parkinsonism Relat Disord; 2014 Nov 01; 20(11):1191-5. PubMed ID: 25219971
    [Abstract] [Full Text] [Related]

  • 26. Regulatory aspects of nigrostriatal dopaminergic neurons.
    Miu P, Karoum F, Toffano G, Commissiong JW.
    Exp Brain Res; 1992 Nov 01; 91(3):489-95. PubMed ID: 1483521
    [Abstract] [Full Text] [Related]

  • 27. Striatal neuropeptide Y neurones are under the influence of the nigrostriatal dopaminergic pathway: immunohistochemical evidence.
    Kerkerian L, Bosler O, Pelletier G, Nieoullon A.
    Neurosci Lett; 1986 May 06; 66(1):106-12. PubMed ID: 2872630
    [Abstract] [Full Text] [Related]

  • 28. Time course of recovery of extracellular dopamine following partial damage to the nigrostriatal dopamine system.
    Robinson TE, Mocsary Z, Camp DM, Whishaw IQ.
    J Neurosci; 1994 May 06; 14(5 Pt 1):2687-96. PubMed ID: 7514209
    [Abstract] [Full Text] [Related]

  • 29. Metabolism of dopamine in the substantia nigra after antidromic activation.
    Korf J, Zieleman M, Westerink BH.
    Brain Res; 1977 Jan 14; 120(1):184-7. PubMed ID: 832118
    [No Abstract] [Full Text] [Related]

  • 30. Cyclosporin A attenuates the decrease in tyrosine hydroxylase immunoreactivity in nigrostriatal dopaminergic neurons and in striatal dopamine content in rats with intrastriatal injection of 6-hydroxydopamine.
    Matsuura K, Makino H, Ogawa N.
    Exp Neurol; 1997 Aug 14; 146(2):526-35. PubMed ID: 9270064
    [Abstract] [Full Text] [Related]

  • 31. The striatonigral fibres and the feedback control of dopamine metabolism.
    Tulloch IF, Arbuthnott GW, Wright AK, Garcia-Munoz M, Nicolaou NM.
    Psychol Med; 1978 Aug 14; 8(3):471-82. PubMed ID: 30106
    [Abstract] [Full Text] [Related]

  • 32. Huntington chorea is not associated with hyperactivity of nigrostriatal dopaminergic neurons: studies in postmortem tissues and in rats with kainic acid lesions.
    Melamed E, Hefti F, Bird ED.
    Neurology; 1982 Jun 14; 32(6):640-4. PubMed ID: 6211637
    [Abstract] [Full Text] [Related]

  • 33. Electrical stimulation of the substantia nigra and changes of 2-phenylethylamine synthesis in the rat striatum.
    Juorio AV, Paterson IA, Zhu MY, Matte G.
    J Neurochem; 1991 Jan 14; 56(1):213-20. PubMed ID: 1670953
    [Abstract] [Full Text] [Related]

  • 34. Morphine and nigrostriatal function in the rat and mouse: the role of nigral and striatal opiate receptors.
    Wood PL, Richard JW.
    Neuropharmacology; 1982 Dec 14; 21(12):1305-10. PubMed ID: 6296716
    [Abstract] [Full Text] [Related]

  • 35. Effects of electrical stimulation of the nigrostriatal pathway of the rat on dopamine metabolism.
    Korf J, Grasdijk L, Westerink BH.
    J Neurochem; 1976 Mar 14; 26(3):579-84. PubMed ID: 1262880
    [No Abstract] [Full Text] [Related]

  • 36. Concentration of striatal tyramine and dopamine metabolism in diabetic rats and effect of insulin administration.
    Kwok RP, Juorio AV.
    Neuroendocrinology; 1986 Mar 14; 43(5):590-6. PubMed ID: 3528901
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Mesolimbic and mesocortical dopamine activation induced by phencyclidine: contrasting pattern to striatal response.
    Deutch AY, Tam SY, Freeman AS, Bowers MB, Roth RH.
    Eur J Pharmacol; 1987 Feb 24; 134(3):257-64. PubMed ID: 3569414
    [Abstract] [Full Text] [Related]

  • 39. Comparison of changes in locomotor activity with striatal homovanillic acid and 3,4-dihydroxyphenylacetic acid concentrations following the bilateral intranigral injection of dopamine agonist drugs in rats.
    Kelly E, Jenner P, Marsden CD.
    J Pharm Pharmacol; 1987 Mar 24; 39(3):196-202. PubMed ID: 2883284
    [Abstract] [Full Text] [Related]

  • 40. Spontaneous recovery from motor asymmetry in adult rats with 6-hydroxydopamine-induced partial lesions of the substantia nigra.
    Dravid A, Jaton AL, Enz A, Frei P.
    Brain Res; 1984 Oct 08; 311(2):361-5. PubMed ID: 6149789
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.